powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1861469249
Joseph Antin
MD
Hematopoietic Cell Transplantation and Cellular Therapy
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
60
Unique beneficiaries
—
Total services
131
Distinct HCPCS
2
Medicare payment
$11K
PRESCRIBING · PART D · 2024
Total Rx claims
365
Beneficiaries
—
Total drug cost
$3.6M
Distinct drugs
10
Brand share
65.8%
Top prescribed drugs
Ruxolitinib Phosphate
80 claims
Belumosudil Mesylate
65 claims
Sulfamethoxazole/Trimethoprim
62 claims
Acyclovir
48 claims
Prednisone
32 claims
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
65.0
Cost
69.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.38%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$14K
Payment records
13
By payment type
Consulting Fee
$14K
Food and Beverage
$273
Top paying entities
Consulting Fee
$14K
Food and Beverage
$273